These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34621704)

  • 1. The use of real-world data in drug repurposing.
    Park K
    Transl Clin Pharmacol; 2021 Sep; 29(3):117-124. PubMed ID: 34621704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design.
    Dagenais S; Russo L; Madsen A; Webster J; Becnel L
    Clin Pharmacol Ther; 2022 Jan; 111(1):77-89. PubMed ID: 34839524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best practices in the real-world data life cycle.
    Zhang J; Symons J; Agapow P; Teo JT; Paxton CA; Abdi J; Mattie H; Davie C; Torres AZ; Folarin A; Sood H; Celi LA; Halamka J; Eapen S; Budhdeo S
    PLOS Digit Health; 2022 Jan; 1(1):e0000003. PubMed ID: 36812509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Pharmacology Applications of Real-World Data and Real-World Evidence in Drug Development and Approval-An Industry Perspective.
    Zhu R; Vora B; Menon S; Younis I; Dwivedi G; Meng Z; Datta-Mannan A; Manchandani P; Nayak S; Tammara BK; Garhyan P; Iqbal S; Dagenais S; Chanu P; Mukherjee A; Ghobadi C;
    Clin Pharmacol Ther; 2023 Oct; 114(4):751-767. PubMed ID: 37393555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe.
    Fanaroff AC; Steffel J; Alexander JH; Lip GYH; Califf RM; Lopes RD
    Eur Heart J; 2018 Aug; 39(32):2932-2941. PubMed ID: 29688403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.
    Rogers JR; Lee J; Zhou Z; Cheung YK; Hripcsak G; Weng C
    J Am Med Inform Assoc; 2021 Jan; 28(1):144-154. PubMed ID: 33164065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications.
    Zou KH; Li JZ; Imperato J; Potkar CN; Sethi N; Edwards J; Ray A
    J Multidiscip Healthc; 2020; 13():671-679. PubMed ID: 32801731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative Program to Evaluate Real World Data for Use in Clinical Studies and Regulatory Decision Making.
    Zozus MN; Choi BY; Garza MY; Facile R; Lanham HJ; Wang Z; Sanns B; Maallah M; Wei HG; Cramer AN; Eisenstein EL
    AMIA Jt Summits Transl Sci Proc; 2023; 2023():632-641. PubMed ID: 37350921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of artificial intelligence in drug development using real-world data.
    Chen Z; Liu X; Hogan W; Shenkman E; Bian J
    Drug Discov Today; 2021 May; 26(5):1256-1264. PubMed ID: 33358699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of Repurposing Drugs and Identifying Contraindications from Real World Study in Parkinson's Disease.
    Tang Y; Yang K; Zhao J; Liang X; Wang J
    ACS Chem Neurosci; 2019 Feb; 10(2):954-963. PubMed ID: 30702853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Real-world Data for New Drug Applications and Line Extensions.
    Bolislis WR; Fay M; Kühler TC
    Clin Ther; 2020 May; 42(5):926-938. PubMed ID: 32340916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement.
    Snyder JM; Pawloski JA; Poisson LM
    Curr Oncol Rep; 2020 Apr; 22(5):45. PubMed ID: 32297007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current Status and Future of the Research Using Real World Data].
    Fujimoto D
    Gan To Kagaku Ryoho; 2022 Dec; 49(12):1300-1304. PubMed ID: 36539238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Real-World Data on Market Authorization, Reimbursement Decision & Price Negotiation.
    Pulini AA; Caetano GM; Clautiaux H; Vergeron L; Pitts PJ; Katz G
    Ther Innov Regul Sci; 2021 Jan; 55(1):228-238. PubMed ID: 32857313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
    Wu J; Wang C; Toh S; Pisa FE; Bauer L
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Real-World Data Challenges Radar: A Review on the Challenges and Risks regarding the Use of Real-World Data.
    Grimberg F; Asprion PM; Schneider B; Miho E; Babrak L; Habbabeh A
    Digit Biomark; 2021; 5(2):148-157. PubMed ID: 34414352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health and Healthcare: Assessing the Real World Data Policy Landscape in Europe.
    Miani C; Robin E; Horvath V; Manville C; Cave J; Chataway J
    Rand Health Q; 2014; 4(2):15. PubMed ID: 28083344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of real-world evidence in severe asthma treatment: challenges and opportunities.
    Lee Y; Lee JH; Park SY; Lee JH; Kim JH; Kim HJ; Kim SH; Chung KF; Song WJ
    ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 37057082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.